Current Clinical Trials

Z1072: "A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma

Sponsored by: American College of Surgeons Oncology Group (ACOSOG); National Cancer Institute (NCI). 

Visica 2™ Treatment System Selected 

The American College of Surgeons Oncology Group (ACOSOG), which just initiated a National Cancer Institute (NCI) funded clinical trial entitled, "A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma," has selected the Visica 2™ Treatment System from Sanarus Technologies as the exclusive technology to be utilized in the cryoablation portion of this study. 

The ACOSOG study protocol (designated as Z1072) will evaluate not only cryoablation but also the ability of Magnetic Resonance Imaging (MRI) to evaluate post-cryoablation efficacy in approximately 100 patients and 20 clinical sites. 

Patient enrollment into the study is currently underway.